Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125066144 | 12506614 | 4 | F | 20160615 | 20160722 | 20160628 | 20160727 | EXP | US-TAKEDA-2016MPI005824 | TAKEDA | 71.68 | YR | M | Y | 81.00000 | KG | 20160727 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125066144 | 12506614 | 1 | PS | Ixazomib | IXAZOMIB | 1 | Oral | 4 MG, UNK | 208462 | 4 | MG | CAPSULE | |||||||
| 125066144 | 12506614 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 125066144 | 12506614 | 3 | C | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Unknown | UNK | 0 | ||||||||||
| 125066144 | 12506614 | 4 | C | HEPARIN | HEPARIN SODIUM | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 125066144 | 12506614 | 5 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | TABLET | |||||||
| 125066144 | 12506614 | 6 | C | ATIVAN | LORAZEPAM | 1 | Oral | 1 MG, UNK | 0 | 1 | MG | TABLET | |||||||
| 125066144 | 12506614 | 7 | C | PERI-COLACE | CASANTHRANOLDOCUSATE SODIUM | 1 | Oral | UNK, BID | 0 | 6.6 | MG | TABLET | BID | ||||||
| 125066144 | 12506614 | 8 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 1000 MG, QD | 0 | 1000 | MG | TABLET | QD | ||||||
| 125066144 | 12506614 | 9 | C | DAPSONE. | DAPSONE | 1 | Oral | 25 MG, BID | 0 | 25 | MG | TABLET | BID | ||||||
| 125066144 | 12506614 | 10 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 50 MG, UNK | 0 | 50 | MG | CAPSULE | |||||||
| 125066144 | 12506614 | 11 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 50 ?G, BID | 0 | 50 | UG | INHALATION POWDER | BID | ||||||
| 125066144 | 12506614 | 12 | C | KRILL OIL | DIETARY SUPPLEMENT | 1 | Oral | UNK | 0 | CAPSULE | |||||||||
| 125066144 | 12506614 | 13 | C | MEVACOR | LOVASTATIN | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | TABLET | |||||||
| 125066144 | 12506614 | 14 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | TABLET | |||||||
| 125066144 | 12506614 | 15 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, QD | 0 | 20 | MG | CAPSULE | QD | ||||||
| 125066144 | 12506614 | 16 | C | K-TAB | POTASSIUM CHLORIDE | 1 | Oral | 10 MEQ, BID | 0 | 10 | MEQ | TABLET | BID | ||||||
| 125066144 | 12506614 | 17 | C | SUNSCREEN | HOMOSALATEOCTINOXATEOCTISALATEOXYBENZONETITANIUM DIOXIDE | 1 | Topical | UNK | U | 0 | LOTION (EXCEPT LOTION FOR EYE) | ||||||||
| 125066144 | 12506614 | 18 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 500 MG, BID | U | 0 | 500 | MG | TABLET | BID | |||||
| 125066144 | 12506614 | 19 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | UNK, QD | U | 0 | TABLET | QD | |||||||
| 125066144 | 12506614 | 20 | C | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | Oral | UNK | U | 0 | |||||||||
| 125066144 | 12506614 | 21 | C | LOPERAMID | LOPERAMIDE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
| 125066144 | 12506614 | 22 | C | LOVASTATIN. | LOVASTATIN | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | TABLET | QD | |||||
| 125066144 | 12506614 | 23 | C | MULTIVITAMIN /07504101/ | VITAMINS | 1 | Oral | UNK, QD | U | 0 | TABLET | QD | |||||||
| 125066144 | 12506614 | 24 | C | VALACYCLOVIR | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 500 MG, UNK | U | 0 | 500 | MG | TABLET | ||||||
| 125066144 | 12506614 | 25 | C | LOSARTAN. | LOSARTAN | 1 | U | 0 | |||||||||||
| 125066144 | 12506614 | 26 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 125066144 | 12506614 | 27 | C | BUDESONIDE. | BUDESONIDE | 1 | Respiratory (inhalation) | UNK, BID | U | 0 | BID | ||||||||
| 125066144 | 12506614 | 28 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | Oral | UNK, QD | U | 0 | QD | ||||||||
| 125066144 | 12506614 | 29 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 125066144 | 12506614 | 30 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, UNK | U | 0 | 40 | MG | |||||||
| 125066144 | 12506614 | 31 | C | KYPROLIS | CARFILZOMIB | 1 | Intravenous (not otherwise specified) | 20 MG/M2, UNK | 0 | 20 | MG/M**2 | ||||||||
| 125066144 | 12506614 | 32 | C | FENTANYL. | FENTANYL | 1 | Intravenous (not otherwise specified) | 100 MG, UNK | 0 | 100 | MG | ||||||||
| 125066144 | 12506614 | 33 | C | ANCEF | CEFAZOLIN SODIUM | 1 | Intravenous (not otherwise specified) | 2 G, UNK | 0 | 2 | G | ||||||||
| 125066144 | 12506614 | 34 | C | POLYETHYLENE GLYCOL | POLYETHYLENE GLYCOLS | 1 | Unknown | 15 MG, Q4HR | 0 | 15 | MG | Q4H | |||||||
| 125066144 | 12506614 | 35 | C | OXYMETAZOLINE | OXYMETAZOLINE | 1 | Unknown | UNK UNK, BID | 0 | BID | |||||||||
| 125066144 | 12506614 | 36 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | 5 MG, UNK | 0 | 5 | MG | ||||||||
| 125066144 | 12506614 | 37 | C | ENALAPRIL | ENALAPRIL | 1 | Unknown | 1.25 MG, QID | 0 | 1.25 | MG | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125066144 | 12506614 | 1 | Plasma cell myeloma |
| 125066144 | 12506614 | 2 | Plasma cell myeloma |
| 125066144 | 12506614 | 3 | Plasma cell myeloma |
| 125066144 | 12506614 | 4 | Deep vein thrombosis |
| 125066144 | 12506614 | 5 | Pain |
| 125066144 | 12506614 | 10 | Pruritus |
| 125066144 | 12506614 | 25 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125066144 | 12506614 | DE |
| 125066144 | 12506614 | HO |
| 125066144 | 12506614 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125066144 | 12506614 | Fatigue | |
| 125066144 | 12506614 | Headache | |
| 125066144 | 12506614 | Plasma cell myeloma | |
| 125066144 | 12506614 | Pulmonary haemorrhage | |
| 125066144 | 12506614 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125066144 | 12506614 | 1 | 20160502 | 20160607 | 0 | |
| 125066144 | 12506614 | 2 | 20160620 | 0 | ||
| 125066144 | 12506614 | 3 | 20150715 | 20160519 | 0 | |
| 125066144 | 12506614 | 6 | 20160531 | 0 | ||
| 125066144 | 12506614 | 7 | 20160502 | 0 | ||
| 125066144 | 12506614 | 8 | 20160502 | 0 | ||
| 125066144 | 12506614 | 11 | 20151223 | 0 | ||
| 125066144 | 12506614 | 12 | 20160502 | 0 | ||
| 125066144 | 12506614 | 14 | 20151223 | 0 | ||
| 125066144 | 12506614 | 15 | 20151223 | 0 | ||
| 125066144 | 12506614 | 16 | 20160208 | 0 | ||
| 125066144 | 12506614 | 20 | 20160119 | 0 | ||
| 125066144 | 12506614 | 21 | 20160502 | 0 | ||
| 125066144 | 12506614 | 22 | 20151223 | 0 | ||
| 125066144 | 12506614 | 23 | 20151228 | 0 | ||
| 125066144 | 12506614 | 24 | 20160207 | 0 | ||
| 125066144 | 12506614 | 31 | 20160621 | 0 |